
Chronic Disease Management Company Lark Health Expands Personalized Weight Management Solutions to Support GLP-1 Medication Demands
Lark Health, a leading conversational-AI health coaching platform, has announced a significant expansion of its personalized weight management solutions. This strategic move is aimed at addressing the surging demand for GLP-1 (Glucagon-like peptide-1) medications among employees, emphasizing Lark’s commitment to comprehensive care for chronic conditions. Lark has developed a new approach to GLP-1 management which encompasses responsible clinical screening, prescribing, ongoing clinical management, and industry-leading behavior change coaching, available 24 hours a day.
As part of this initiative, Lark introduces three new programs:
- Healthy Weight Program: Lark’s weight loss program employs AI-driven holistic personalized coaching that focuses on lifestyle modification. It covers critical aspects such as nutrition, physical activity, sleep, and stress management, empowering members to achieve sustainable weight loss. Additionally, it offers employers a cost-effective alternative to pricier GLP-1 solutions.
- GLP-1 Companion Program: Designed for individuals already on GLP-1 medications, this comprehensive support program extends beyond lifestyle modification coaching. It includes side effect management, medication adherence support, and clinical escalations as needed, ensuring a well-rounded approach to GLP-1 therapy.
- Clinician-Guided Step Therapy Program: This program offers end-to-end clinician-led therapy, providing insurance navigation, prescription management, lab monitoring, and ongoing care management to ensure seamless and continuous healthcare support.
These expanded offerings build upon Lark’s successful track record as one of the largest providers of diabetes prevention programs (DPP) and weight loss solutions for health plans. Lark’s DPP is recognized by the Centers for Disease Control and Prevention (CDC) as a lifestyle change program and holds the CDC’s highest certification level, Full Recognition. A recent study in the Annals of Behavioral Medicine established Lark as the first digital health solution to demonstrate improvements in patient cardiac self-efficacy scores.
Julia Hu, Lark CEO, and Co-Founder reiterates Lark’s commitment to responsible healthcare innovation, emphasizing the organization’s history of using technology and AI to assist more than 2 million patients in coaching and education for the prevention or management of chronic conditions with over 500 million coaching messages delivered.